It has been observed that the risk of tumor development increases steeply as CD4+ T-cell counts decline below a certain threshold, nevertheless, once below this threshold, cancer risk becomes less dependent on further CD4+ T-cell loss19. This evidence concerns the gene CD4 and neoplasm.